Amedisys (AMED) Tops Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.25, $0.14 better than the analyst estimate of $1.11. Revenue for the quarter came in at $594.8 million versus the consensus estimate of $597.47 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Midera Food Processing and Centrus Energy to join S&P SmallCap 600
- Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
